Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality

被引:1305
作者
Classen, DC
Pestotnik, SL
Evans, RS
Lloyd, JF
Burke, JP
机构
[1] Department of Clinical Epidemiology, LDS Hospital, Salt Lake City, UT
[2] Department of Clinical Epidemiology, LDS Hospital, Salt Lake City, UT 84143, Eighth Avenue and C Street
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1997年 / 277卷 / 04期
关键词
D O I
10.1001/jama.277.4.301
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective.-To determine the excess length of stay, extra costs, and mortality attributable to adverse drug events (ADEs) in hospitalized patients. Design.-Matched case-control study. Setting.-The LDS Hospital, a tertiary care health care institution. Patients.-All patients admitted to LDS Hospital from January 1, 1990, to December 31, 1993, were eligible. Cases were defined as patients with ADEs that occurred during hospitalization; controls were selected according to matching variables in a stepwise fashion. Methods.-Controls were matched to cases on primary discharge diagnosis related group (DRG), age, sex, acuity, and year of admission; varying numbers of controls were matched to each case. Matching was successful for 71% of the cases, leading to 1580 cases and 20197 controls. Main Outcome Measures.-Crude and attributable mortality, crude and attributable length of stay, and cost of hospitalization. Results.-ADEs complicated 2.43 per 100 admissions to the LDS Hospital during the study period. The crude mortality rates for the cases and matched controls were 3.5% and 1.05%, respectively (P<.001). The mean length of hospital stay significantly differed between the cases and matched controls (7.69 vs 4.46 days; P<.001) as did the mean cost of hospitalization ($10 010 vs $5355; P<.001). The extra length of hospital stay attributable to an ADE was 1.74 days (P<.001). The excess cost of hospitalization attributable to an ADE was $2013 (P<.001). A linear regression analysis for length of stay and cost controlling for all matching variables revealed that the occurrence of an ADE was associated with increased length of stay of 1.91 days and an increased cost of $2262 (P<.001). In a similar logistic regression analysis for mortality, the increased risk of death among patients experiencing an ADE was 1.88 (95% confidence interval, 1.54-2.22; P<.001). Conclusion.-The attributable lengths of stay and costs of hospitalization for ADEs are substantial. An ADE is associated with a significantly prolonged length of stay, increased economic burden, and an almost 2-fold increased risk of death.
引用
收藏
页码:301 / 306
页数:6
相关论文
共 42 条
[1]  
[Anonymous], HOSP PHARM
[2]  
[Anonymous], 1992, Hospital pharmacy
[3]   INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION [J].
BATES, DW ;
CULLEN, DJ ;
LAIRD, N ;
PETERSEN, LA ;
SMALL, SD ;
SERVI, D ;
LAFFEL, G ;
SWEITZER, BJ ;
SHEA, BF ;
HALLISEY, R ;
VANDERVLIET, M ;
NEMESKAL, R ;
LEAPE, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01) :29-34
[4]   11 WORTHY AIMS FOR CLINICAL LEADERSHIP OF HEALTH SYSTEM REFORM [J].
BERWICK, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 272 (10) :797-802
[5]  
Bloom B S, 1988, Am J Med, V84, P20, DOI 10.1016/0002-9343(88)90250-1
[6]   DRUG-INDUCED ILLNESS LEADING TO HOSPITALIZATION [J].
CARANASOS, GJ ;
STEWART, RB ;
CLUFF, LE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1974, 228 (06) :713-717
[7]   SELF-REPORTED ADVERSE DRUG-REACTIONS AND RELATED RESOURCE USE - A STUDY OF COMMUNITY-DWELLING PERSONS 65 YEARS OF AGE AND OLDER [J].
CHRISCHILLES, EA ;
SEGAR, ET ;
WALLACE, RB .
ANNALS OF INTERNAL MEDICINE, 1992, 117 (08) :634-640
[8]  
CLASSEN D, 1993, THESIS U UTAH SALT L
[9]  
Classen D C, 1992, Hosp Pharm, V27, P776
[10]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851